Efficacy and tolerance of an oral enzyme combination in painful osteoartritis of the hip. A double - Blind, randomised study comparing oral enzymes with non-steroidal anti-inflammatory drugs

Clinical and Experimental Rheumatology

Volumn 24, Issue 1, 2006, Pages 25-30

  Klein, G ^a,b   Kullich, Werner ^b   Schnitker, J ^c   Schwann, H ^a  

^a Rehabilitation Centre for Cardiovascular and Rheumatic Diseases   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c Institut für Angewandte Statistik   (Germany)

Author keywords

Diclofenac; Oral enzymes; Osteoarthritis of the hip; Pain; Randomised trial

Indexed keywords

ALLVORAN; DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; PHLOGENZYM; PHYLOGENZYM;

ADULT; ANALYSIS OF VARIANCE; ANEMIA; ARTHRALGIA; ARTICLE; AUSTRIA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; ENTERIC COATED TABLET; ENZYME THERAPY; FEMALE; GASTROINTESTINAL TOXICITY; HIP OSTEOARTHRITIS; HUMAN; JOINT FUNCTION; JOINT STIFFNESS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PARALLEL DESIGN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; STUDENT T TEST; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACTIVITIES OF DAILY LIVING; ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BROMELAINS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; PAIN; PAIN MEASUREMENT; RUTIN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TRYPSIN;

EID: 33645061272     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. McCABE CJ, AKEHURST RL, KIRSCH J et al.: Choice of NSAID and management strategy in rheumatoid arthritis and osteoarthritis. The impact on costs and outcome in the UK. Pharmacoeconomics 1998; 14: 191-9.
2. CREAMER P, HOCHBERG MC: Osteoarthritis. Lancet 1997; 350: 503-8.
3. LING SM, BATHON JM: Osteoarthritis in the older adults. J AmGeriatrSoc 1998;46:216-25.
4. BROOKS P: Use and benefits of nonsteroidal anti-inflammatory drugs. Am J Med 1998; 104: 9S-13S; discussion 21S-22S.
5. ROTH SH, BENNETT RE: Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response. Arch Intern Med 1987; 147: 2093-100.
6. GARCIA-RODRIGUEZ LA, JICK H: Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-72.
7. LANGMAN MJ, WEIL J, WAINWRIGHT P et al.: Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-8.
8. WITTENBORG A, BOCK PR, HANISCH J, SALLER R, SCHNEIDER B: Comparative epidemiological study in patients with rheumatic diseases illustrated in an example of a treatment with non-steroidal anti-inflammatory drugs versus an oral enzyme combination. Arzneim-Forsch/Drug Res 2000; 50 (II): 728-38.
9. AKHTAR NM, NASEER R, FAROOQI AZ, AZIZ W, NAZIR M: Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee - a double-blind prospective randomized study. Clin Rheumatol 2004 (published online 24 July 2004).
10. SINGER F, SINGER C, OBERLEITNER H: Phlogenzym versus diclofenac in the treatment of activated osteoarthritis of the knee. A double-blind prospective randomized study. Int J Immunotherapy 2001; XVII (2/3/4) 135-41.
11. KLEIN G, KULLICH W: Short-term treatment of painful osteoarthritis of the knee with oral enzymes. A randomised, double-blind study versus diclofenac. Clin Drug Invest 2000; 19: 15-23.
12. SAWAI Y, KOHSAKA K, NISHIYAMA Y, ANDO K: Serum concentration of rutoside metabolites after oral administration of a rutoside formulation to humans. Arzneimittel-Forschung 1987; 37: 729-32.
13. MIYAKE K, ARIMA H, HIRAYAMA F et al.: Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin. Pharm Dev Tech 2000; 5: 399-407.
14. KELLY GS: Bromelain: a literature review and discussion of its therapeutic applications. Alt Med Rev 1996; 1: 243-57.
15. KLASCHKA F: Oral enzymes - new approach to cancer treatment: immunological concepts for general and clinical practice; complementary cancer treatment. Gräfelfing: Forum-Med.-Verl.-Ges 1996.
16. KARBOWSKI A, SCHWITALLE M, ECKARDT A: Oxaprozin versus diclofenac retard in treated of activated arthrosis. Z Rheumatol 1998; 57: 108-13.
17. LEQUESNE MG, MERY C, SAMSON M, GERARD P: Indexes of severity for osteoarthritis of the hip and knee. Validation - value in comparison with other assessment tests. Scand J Rheumatol 1987; 65 (Suppl.): 85-9.
18. BELLAMY N: WOMAC: A 20-year experimental review of a patient-centered self-reported health status questionnaire. J Rheumatol 2002; 29: 2473-6.
19. O'BRIEN PC: Procedures for comparing samples with multiple endpoints. Biometrics 1984; 40: 1079-87.
20. LEHMACHER W, WASSMER G, REITMEIR P: Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate. Biometrics 1991; 47: 511-21.
21. DOUGADOS M, LECLAIRE P, van der HEIJDE D, BLOCH DA, BELLAMY N, ALTMAN RD: Response criteria for clinical trials on osteoarthritis of the knee and hip: A report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative. Osteoarthritis Cartilage 2000; 8: 395-403.
22. SINGER F, OBERLEITNER H: Drug therapy of activated arthrosis. On the effectiveness of an enzyme mixture versus diclofenac. Wien Med Wochenschr 1996; 146: 55-8.
23. CHEVALIER X, MARRE JP, de BUTLER J, HERCEK A: Questionnaire survey of management and prescription of general practitioners in knee osteoarthritis: a comparison with 2000 EULAR recommendations. Clin Exp Rheumatol 2004; 22: 205-12.
24. FRIES JF, WILLIAMS CA, BLOCH DA: The relative toxicity of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1991; 34: 1353-60.
25. KLEIN G, KULLICH W: Enzymes for gonarthrosis. As effective as NSAID, or not? Mmw Fortschritte Der Medizin 2000; 142: 10.
26. KLEIN G, KULLICH W: Reducing pain by oral enzyme therapy in rheumatic diseases. Wien Med Wochenschr 1999; 149: 577-80.